Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,913 GBX | +3.18% | +6.34% | +6.93% |
12:50pm | HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets | |
Apr. 25 | Hikma Pharmaceuticals backs outlook after making strong start to 2024 | AN |
Evolution of the average Target Price on Hikma Pharmaceuticals PLC
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Hikma Pharmaceuticals PLC
alphavalue | Abhishek Raval |
RBC Capital Markets | |
JPMorgan | |
Jefferies & Co. | |
Barclays | |
Berenberg Bank | |
Morgan Stanley | |
Goldman Sachs | |
Citigroup |
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HIK Stock
- Consensus Hikma Pharmaceuticals PLC